Catalent | CTLT - Vermögenswerte



Vermögenswerte Veränderung Datum
Agilent USD 12.81B 86M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Bruker USD 6.24B 193.5M 2025-12
Centene USD 76.75B 5.34B 2025-12
Charles River Laboratories USD 7.14B 378.39M 2025-12
Cigna USD 157.92B 0 2025-12
Danaher USD 83.46B 3.57B 2025-12
Dentsply International USD 5.43B 224M 2025-12
Elevance Health USD 121.49B 1.26B 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
Glaxosmithkline GBP 82.45B 23.19B 2025-09
Hologic USD 9.18B 165.8M 2025-12
Humana USD 48.91B 810M 2025-12
Illumina USD 6.64B 467M 2025-12
Intuitive Surgical USD 20.46B 1.11B 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
J&J USD 199.21B 6.39B 2025-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Lonza CHF 19.73B 1.85B 2024-12
McKesson USD 84.19B 30M 2025-12
Merck EUR 50.93B 3.58B 2025-09
Merck USD 129.55B 12.02B 2025-09
Mettler Toledo International USD 3.71B 191.18M 2025-12
Novartis USD 107.29B 2.89B 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Quest Diagnostics USD 16.23B 28M 2025-12
Repligen USD 2.95B 25.99M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Supernus Pharmaceuticals USD 1.45B 32.89M 2025-12
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
UnitedHealth USD 309.58B 5.69B 2025-12
Veradigm USD 1.69B 23.56M 2022-09
Waters USD 5.08B 221.41M 2025-12
West Pharmaceutical Services USD 4.27B 164.2M 2025-12